Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis Is Associated with Increased Resistance to Ceftriaxone and Carbapenems

Kavindra V. Singh, Barbara E. Murray
Kavindra V. Singh
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USAUTHealth Center for Antimicrobial Resistance and Microbial Genomics (CARMiG), University of Texas Medical School at Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara E. Murray
Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USADepartment of Microbiology and Molecular Genetics, University of Texas Medical School at Houston, Texas, USAUTHealth Center for Antimicrobial Resistance and Microbial Genomics (CARMiG), University of Texas Medical School at Houston, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.00481-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

The enterococcal polysaccharide antigen (Epa) locus of Enterococcus faecalis encodes enzymes and transporters involved in E. faecalis cell wall polysaccharide metabolism (1–3). We previously showed that deletion of epaB (which encodes a putative glycosyl transferase and possibly mediates transfer of rhamnose to cell wall polysaccharides [1]) and disruption of several other epa genes resulted in reduced virulence in murine peritonitis (1, 2) and urinary tract infection (4) models. In addition, OG1RFΔepaB and disruption of epaB were impaired in colitogenic activity in IL-10–/– mice (5) and showed lysozyme susceptibility (5), attenuation in nonvertebrate models (5), translocation (1), biofilm formation, resistance to polymorphonuclear leukocyte killing, susceptibility to NPV-1 phage (1), and marked alteration in cell morphology, suggesting a role for Epa in cell wall synthesis or function (1).

A recent study on Enterococcus hirae LcpA (Psr) (6) postulated that LcpA catalyzes the attachment of “rhamnose-containing polysaccharides” onto the cell’s peptidoglycan (6). Reasoning that altering rhamnose-containing polysaccharides of E. faecalis could alter its peptidoglycan and thus the activity of beta-lactams, we examined our E. faecalis epa mutants, including those lacking cell wall rhamnose, to determine whether the MICs of select beta-lactams against these mutants differ versus OG1RF.

The strains used included wild-type (WT) OG1RF (7, 8), OG1RFΔepaB, reconstituted OG1RFΔepaB::epaB (5, 9), and several epa disruption mutants (1, 2) [OG1RFepaA::aph(3′)-IIIa, OG1RFepaB::aph(3′)-IIIa, OG1RFepaE::aph(3′)-IIIa, OG1RFepaL::aph(3′)-IIIa, and OG1RFepaN::aph(3′)-IIIa] representing different transcripts of the epa gene cluster.

MICs were determined with Etest strips of ceftriaxone (CRO), ampicillin (AMP), doripenem (DOR), meropenem (MEM), and daptomycin (DAP; which acts via unrelated mechanisms) (AB Biodisk, Solna, Sweden; Liofilchem, Inc., Waltham, MA) on cation-adjusted Mueller-Hinton II (Oxoid, UK) agar plates. MICs were read according to the manufacturer’s guidelines, and MIC determinations were repeated at least twice with reproducible results. Table 1 shows the MICs of test antibiotics against WT OG1RF and epa mutants.

View this table:
  • View inline
  • View popup
TABLE 1

MICs against WT and epa locus mutants of E. faecalis OG1RF

The CRO MIC increased from 24 μg/ml (OG1RF and OG1RFΔepaB::epaB) to >256 μg/ml with OG1RFΔepaB and the disruption mutants, including OG1RFepaA::aph(3′)-IIIa, which has the most growth impairment (1). The DOR and MEM MICs were also considerably higher with epa mutants than with OG1RF and OG1RFΔepaB::epaB.

AMP MIC differences were modest between OG1RF and the epa mutants and the growth impaired OG1RFepaA::aph(3′)-IIIa mutant did not show any change. The DAP MIC was the same for all strains except OG1RFepaA::aph(3′)-IIIa, likely due to its growth impairment.

Our previous data on polysaccharide (PS) content showed that a major polysaccharide band was missing in epa disruption mutants and was restored in the epaB complemented strain (1). In addition, our analyses of purified polysaccharide (Epa) from WT OG1RF and the OG1RFepaB::aph(3′)-IIIa mutant showed that Epa is composed of glucose, rhamnose, N-acetylglucosamine, N-acetylgalactosamine, and galactose, while there was no rhamnose present in Epa purified from the OG1RFepaB::aph(3′)-IIIa but, instead, mannose was present (1).

Our results indicate that altered cell wall polysaccharide content, such as lack of rhamnose and/or the presence of mannose in epa mutant cell walls, is associated with marked resistance to CRO, DOR, and, MEM. The mechanism for resistance remains to be determined.

ACKNOWLEDGMENT

We thank Karen Jacques-Palaz for technical assistance.

  • Copyright © 2019 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Teng F,
    2. Singh KV,
    3. Bourgogne A,
    4. Zeng J,
    5. Murray BE
    . 2009. Further characterization of the epa gene cluster and Epa polysaccharides of Enterococcus faecalis. Infect Immun 77:3759–3767. doi:10.1128/IAI.00149-09.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Xu Y,
    2. Singh KV,
    3. Qin X,
    4. Murray BE,
    5. Weinstock GM
    . 2000. Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect Immun 68:815–823. doi:10.1128/IAI.68.2.815-823.2000.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Hancock LE,
    2. Gilmore MS
    . 2002. The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A 99:1574–1579. doi:10.1073/pnas.032448299.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Singh KV,
    2. Lewis RJ,
    3. Murray BE
    . 2009. Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection. J Infect DIS 200:417–420. doi:10.1086/600124.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Ocvirk S,
    2. Sava IG,
    3. Lengfelder I,
    4. Lagkouvardos I,
    5. Steck N,
    6. Roh JH,
    7. Tchaptchet S,
    8. Bao Y,
    9. Hansen JJ,
    10. Huebner J,
    11. Carroll IM,
    12. Murray BE,
    13. Sartor RB,
    14. Haller D
    . 2015. Surface-associated lipoproteins link Enterococcus faecalis virulence to colitogenic activity in IL-10-deficient mice independent of their expression levels. PLoS Pathog 11:e1004911. doi:10.1371/journal.ppat.1004911.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Marechal M,
    2. Amoroso A,
    3. Morlot C,
    4. Vernet T,
    5. Coyette J,
    6. Joris B
    . 2016. Enterococcus hirae LcpA (Psr), a new peptidoglycan-binding protein localized at the division site. BMC Microbiol 16:239. doi:10.1186/s12866-016-0844-y.
    OpenUrlCrossRef
  7. 7.↵
    1. Bourgogne A,
    2. Garsin DA,
    3. Qin X,
    4. Singh KV,
    5. Sillanpaa J,
    6. Yerrapragada S,
    7. Ding Y,
    8. Dugan-Rocha S,
    9. Buhay C,
    10. Shen H,
    11. Chen G,
    12. Williams G,
    13. Muzny D,
    14. Maadani A,
    15. Fox KA,
    16. Gioia J,
    17. Chen L,
    18. Shang Y,
    19. Arias CA,
    20. Nallapareddy SR,
    21. Zhao M,
    22. Prakash VP,
    23. Chowdhury S,
    24. Jiang H,
    25. Gibbs RA,
    26. Murray BE,
    27. Highlander SK,
    28. Weinstock GM
    . 2008. Large-scale variation in Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. Genome Biol 9:R110. doi:10.1186/gb-2008-9-7-r110.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Murray BE,
    2. Singh KV,
    3. Ross RP,
    4. Heath JD,
    5. Dunny GM,
    6. Weinstock GM
    . 1993. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J Bacteriol 175:5216–5223. doi:10.1128/jb.175.16.5216-5223.1993.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Panesso D,
    2. Montealegre MC,
    3. Rincon S,
    4. Mojica MF,
    5. Rice LB,
    6. Singh KV,
    7. Murray BE,
    8. Arias CA
    . 2011. The hylEfm gene in pHylEfm of Enterococcus faecium is not required in pathogenesis of murine peritonitis. BMC Microbiol 11:20. doi:10.1186/1471-2180-11-20.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis Is Associated with Increased Resistance to Ceftriaxone and Carbapenems
Kavindra V. Singh, Barbara E. Murray
Antimicrobial Agents and Chemotherapy Apr 2019, 63 (5) e00481-19; DOI: 10.1128/AAC.00481-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis Is Associated with Increased Resistance to Ceftriaxone and Carbapenems
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
Share
Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis Is Associated with Increased Resistance to Ceftriaxone and Carbapenems
Kavindra V. Singh, Barbara E. Murray
Antimicrobial Agents and Chemotherapy Apr 2019, 63 (5) e00481-19; DOI: 10.1128/AAC.00481-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENT
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Enterococcus faecalis
Epa

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596